Overview
Samuel Anandan is a Palliative Medicine provider practicing medicine in Staten Island, New York.
His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Alzheimer's Disease, and Dementia.
Dr. Anandan is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Hospice & Palliative Medicine. He is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Graduate Institution
Residency
Specialties
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
Locations
Additional Areas of Focus
Dr. Anandan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Phelps Medical Services PC
Paul Glare is a Palliative Medicine provider practicing medicine in Sleepy Hollow, New York. Dr. Glare is highly rated in 1 condition, according to our data. His clinical expertise encompasses Chronic Pain.
St Lukes Hospital
Christie Mulholland is a Palliative Medicine provider practicing medicine in New York, New York. Dr. Mulholland is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Opioid Induced Constipation.
Davinder Kumar is a primary care provider, practicing in Palliative Medicine in Plainview, New York. Dr. Kumar is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Sepsis, Hypertensive Heart Disease, End-Stage Renal Disease (ESRD), Gastrostomy, and Endoscopy. Dr. Kumar is board certified in American Board Of Internal Medicine.
Frequently Asked Questions about Dr. Samuel R. Anandan
Is Dr. Samuel R. Anandan a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samuel R. Anandan is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Samuel R. Anandan specialize in?
While Dr. Samuel R. Anandan is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Alzheimer's Disease, and Dementia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Samuel R. Anandan participate in research or clinical trials?
Yes. Dr. Samuel R. Anandan has published 4 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Samuel R. Anandan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Samuel R. Anandan accept my insurance?
Dr. Samuel R. Anandan accepts most major insurance plans, including Humana and Northwell Health. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Anandan isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.